Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J. Thompson, Jeffrey A. Cohen, Brenda Banwell et al.|The Lancet Neurology|2017Cited by 8k
Defining the clinical course of multiple sclerosisFred Lublin, Chris H. Polman, Gary Cutter et al.|Neurology|2014Cited by 3.1k
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesLudwig Kappos, Rupert Sandbrink, C. H. Polman et al.|Neurology|2006Cited by 677
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and ProgressionAlberto Ascherio, Christoph Pohl, Kassandra L. Munger et al.|JAMA Neurology|2014Cited by 514
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT studyLudwig Kappos, Rupert Sandbrink, Mark S. Freedman et al.|The Lancet|2007Cited by 502